- Home
- Software Solutions
- Resources
- Corporate
A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
Sponsors:
| Phases:
| |
| Indications | Acronym: FEATURE | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 300 | |
Additional information about NCT00673920.